NCT05127148View on ClinicalTrials.gov

RWE of Pediatric-like Protocol for AYA Patients With Ph-negative ALL

RecruitingOBSERVATIONAL
Enrollment

100

Participants

Timeline

Start Date

March 1, 2021

Primary Completion Date

March 1, 2026

Study Completion Date

December 1, 2026

Conditions
Acute Lymphoblastic Leukemia, Adult
Interventions
OTHER

Evaluation of survival and toxicities in AYA Ph-negative ALL patients treating in first line depending on risk category.

Evaluation of survival (event free survival and overall survival) and toxicities in AYA Ph-negative ALL patients treating in first line with argentinian pediatric-like protocol depending on risk category.

Trial Locations (2)

Unknown

RECRUITING

Instituto Privado de Hematologia y Hemoterapia, Paraná

RECRUITING

FUNDALEU, CABA

All Listed Sponsors
lead

Grupo Argentino de Tratamiento de la Leucemia Aguda

OTHER